Equibles does not estimate personal net worth.
Neil Kumar Ph.D was last confirmed as CEO and Board Member at BridgeBio Pharma, Inc. (BBIO) in a filing dated April 30, 2025. Neil Kumar Ph.D has spoken on 1 investor event across 1 company, most recently for BridgeBio Pharma, Inc. on June 9, 2026. The companies whose calls Neil Kumar Ph.D spoke on are classified in the Healthcare sector.
“So we're incredibly pleased to see the strong growth of the ATTRCM market. Maybe I'll just break about the market into the two segments, first line and second line.”
Start not stated–2025-04-30
Last confirmed by a filing; no departure on record
Start not stated–2025-04-30
Last confirmed by a filing; no departure on record
Biotechnology · Healthcare
CEO, Board Member
